FDA Commissioner resigns just months after taking on the position.
FDA Commissioner Lester Crawford has resigned his position just two months following his cofirmation by the Senate, according to the Wall Street Journal.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.